Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
Open Access
- 16 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e69896
Abstract
Biomarkers to differentiate between active tuberculosis (TB) and latent TB infection (LTBI) and to monitor treatment responses are requested to complement TB diagnostics and control, particularly in patients with multi-drug resistant TB. We have studied soluble markers of the Toll-like-receptor 4 (TLR-4) pathway in various stages of TB disease and during anti-TB treatment. Plasma samples from patients with culture confirmed drug-sensitive TB (n = 19) were collected before and after 2, 8 and 24 weeks of efficient anti-TB treatment and in a LTBI group (n = 6). Soluble (s) CD14 and myeloid differentiation-2 (MD-2) were analyzed by the Enzyme-linked immunosorbent assay (ELISA). Lipopolysaccharide (LPS) was analyzed by the Limulus Amebocyte Lysate colorimetric assay. Nonparametric statistics were applied. Plasma levels of sCD14 (p<0.001), MD-2 (p = 0.036) and LPS (p = 0.069) were elevated at baseline in patients with untreated active TB compared to the LTBI group. MD-2 concentrations decreased after 2 weeks of treatment (p = 0.011), while LPS levels decreased after 8 weeks (p = 0.005). In contrast, sCD14 levels increased after 2 weeks (p = 0.047) with a subsequent modest decrease throughout the treatment period. There was no significant difference in concentrations of any of these markers between patients with pulmonary and extrapulmonary TB or between patients with or without symptoms. Our data suggest that plasma levels of LPS, MD-2 and sCD14 can discriminate between active TB and LTBI. A decline in LPS and MD-2 concentrations was associated with response to anti-TB treatment. The clinical potential of these soluble TLR-4 pathway proteins needs to be further explored.Keywords
This publication has 43 references indexed in Scilit:
- Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic ReviewPLOS Medicine, 2007
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- Roles for accessory molecules in microbial recognition by Toll-like receptorsInnate Immunity, 2006
- Soluble MD-2 activity in plasma from patients with severe sepsis and septic shockBlood, 2004
- Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4Immunology, 2004
- Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune responseMolecular Microbiology, 2004
- Serum Concentrations of Lipopolysaccharide Activity–Modulating Proteins during TuberculosisThe Journal of Infectious Diseases, 1998
- Selective Increase in Plasma Tumor Necrosis Factor- and Concomitant Clinical Deterioration after Initiating Therapy in Patients with Severe TuberculosisThe Journal of Infectious Diseases, 1998
- Structure-function analysis of soluble and membrane-bound CD14.1998
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993